The company’s APAS Independence is an innovative platform technology that automates culture-plate screening and interpretation
It automatically evaluates bacteria that cause infections in the body
This reduces time and costs, and outlines a more streamlined process
John Hopkins study has vindicated LBT
Great announcement just before market close today saw LBT jump from 19.5c to 23c (possible distribution agreement seems to be in the pipeline near term so plenty of "blue sky" potential imo)
Healthy bullish looking chart augurs well too as LBT are cashed up going forward.
